title: [Correct use of serotonin agonists in migraine: oral or injectable form?].
abstract: Sumatriptan and other selective serotonin agonists represent a major breakthrough in acute migraine treatment. These drugs are very efficacious and generally devoided of important side effects, but they are expensive and therefore have to be compared with other, more conventional drugs with established or assumed efficacy. We summarize the pharmacologic characteristics of Sumatriptan and give recommendations about its use in clinical practice.
authors.affiliation: Service de Neurologie, Hôpital Erasme, U.L.B.
authors.forename: A
authors.initials: A
authors.lastname: Joffroy
mesh_terms: D000284:Administration, Oral; D006801:Humans; D007279:Injections, Subcutaneous; D008881:Migraine Disorders / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D018579:Patient Selection; D017366:Serotonin Receptor Agonists / Q000008:administration & dosage*
chemical_list: D017366:Serotonin Receptor Agonists